PNC
55
3
KSS
23
2
GM
44
4
MS
53
5
AON
80
5
CAH
61
5
CB
51
4
NOV
45
5
GOOGL
45
2
T
71
3
TGNA
66
2
HSY
47
-4
WFC
72
3
TJX
48
11
LOW
36
2
HAL
50
6
M
27
-3
BK
68
5
NVDA
56
4
LNC
58
8
PNC
55
3
KSS
23
2
GM
44
4
MS
53
5
AON
80
5
CAH
61
5
CB
51
4
NOV
45
5
GOOGL
45
2
T
71
3
TGNA
66
2
HSY
47
-4
WFC
72
3
TJX
48
11
LOW
36
2
HAL
50
6
M
27
-3
BK
68
5
NVDA
56
4
LNC
58
8
Financhill
Back

Structure Therapeutics Stock Predictions

Economy going through a "period of transition" - Your portfolio doesn't have to

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17

GPCR
Structure Therapeutics

Last Price:
$22.17
Seasonality Move:
47.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Structure Therapeutics Stock Forecast

  • Over the next 52 weeks, Structure Therapeutics has on average historically risen by 5.1% based on the past 2 years of stock performance.
  • Structure Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Structure Therapeutics Stock Undervalued?
    The current Structure Therapeutics [GPCR] share price is $21.05. The Score for GPCR is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Structure Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Structure Therapeutics has on average historically risen by 5.1% based on the past 2 years of stock performance.

Structure Therapeutics Stock Rating

Sell
17
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics overpriced?

  • Structure Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Structure Therapeutics Stock Price History

Is GPCR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
structuretx.com

52-Week Data

52-Week High:
62.74
52-Week Low:
19.39

Prediction Charts

Market Cap:
1.2B
Price in USD:
21.05
Volume:
786.7K
Beta:
-2.46

Technical Analysis

SMA50:
25.69
SMA100:
30.30
SMA200:
35.40
52-Wk Change:
-40.16%

Stock Predictions

  • Is Structure Therapeutics stock public?
    Yes, Structure Therapeutics is a publicly traded company.
  • What is the Structure Therapeutics stock quote today?
    The Structure Therapeutics stock price is 21.05 USD today.
  • How to buy Structure Therapeutics stock online?
    You can buy Structure Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-21 23.40 23.77 24.87 23.36
Feb-25 21.02 21.09 21.50 20.12
Feb-26 21.23 19.88 21.48 19.61
Feb-27 19.96 22.80 23.33 19.64
Feb-28 23.20 23.75 24.13 21.55
Mar-3 23.77 22.36 23.77 21.83
Mar-4 22.06 22.49 22.80 20.45
Mar-5 22.47 22.57 23.43 21.79
Mar-6 22.00 23.53 23.57 21.85
Mar-7 23.08 22.62 23.29 22.09
Mar-11 20.02 20.53 20.60 19.39
Mar-12 22.26 21.42 23.00 21.10
Mar-13 21.50 20.40 22.52 19.89
Mar-14 20.58 21.05 21.49 20.27

Structure Therapeutics Earnings

Structure Therapeutics Earnings Report: Per Share Structure Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Structure Therapeutics Forecast Revenue Growth

Structure Therapeutics Stock Analysis: Historical quarterly revenues per share for Structure Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.08 per share, and a decrease next year of $0.68 per share.

* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.